EPN (Euphorinol)

EPN (Euphorinol) – Bulk and Wholesale

EPN — also known as Euphorinol — is a specialty hemp-derived cannabinoid analog produced through cannabinoid synthesis processes for use in differentiated multi-cannabinoid product programs. As a specialty cannabinoid input, EPN occupies a niche position in the rare-cannabinoid catalog and is sought by formulators developing branded multi-cannabinoid SKUs around novel-cannabinoid content. Available in bulk and wholesale quantities from 100 grams through 100+ kilogram tiers with significantly reduced pricing at higher volume. Material is produced in cGMP-compliant facilities and third-party tested through ISO 17025-accredited laboratories. EPN carries specific compliance considerations as a specialty cannabinoid analog — buyers should verify regulatory status in target distribution markets and consult legal counsel before purchasing.

Product Specifications

• Product Type: Specialty hemp-derived cannabinoid analog (EPN / Euphorinol)
• Primary Cannabinoid: EPN (Euphorinol) — specialty cannabinoid
• Form / Appearance: Viscous oil; color varies by batch refinement
• Cannabinoid Content: See batch-specific COA for verified concentration
• Delta-9 THC Content: ≤0.3% by dry weight (Farm Bill compliant on Delta-9 metric)
• Solubility: Insoluble in water; soluble in oils, ethanol, and other lipid carriers
• Source: USA-grown licensed hemp source material
• Available Sizes: 100g, 250g, 500g, 1kg, 5kg, 10kg, 25kg, 50kg, 100kg+
• Storage: Cool, dry, light-protected (see Storage and Handling)
• Typical Shelf Life: 12 months sealed under proper conditions
• Lead Time: 1–3 business days for in-stock inventory; longer for custom volumes
• Critical Note: EPN carries specific compliance considerations — see Compliance section

What Is EPN (Euphorinol)?

EPN, also marketed under the name Euphorinol, is a specialty hemp-derived cannabinoid analog produced through cannabinoid synthesis processes. As a specialty cannabinoid input, EPN sits in the broader category of novel cannabinoid compounds developed for differentiated finished-product positioning in the hemp-derived market. The exact molecular structure and synthesis pathway for EPN are detailed in batch-specific product documentation and Certificates of Analysis. As with other novel cannabinoid analogs, EPN occupies a regulatory category that is evolving — both at the federal level under the Federal Analog Act framework and at the state level where novel-cannabinoid restrictions vary significantly. Buyers sourcing EPN are typically specialty manufacturers building branded SKUs around novel-cannabinoid content for permissive retail markets with established compliance review protocols.

How EPN (Euphorinol) Is Produced

1. Source Material. USA-grown licensed hemp source material meeting Farm Bill cultivation standards provides the cannabinoid starting material.

2. Specialty Synthesis. EPN is produced through specialized cannabinoid synthesis processes in facilities equipped for novel-cannabinoid production with appropriate quality control infrastructure.

3. Refinement. The synthesis product undergoes refinement and purification to achieve commercial specifications.

4. Compliance Verification. Every batch undergoes ISO 17025-accredited third-party testing documenting the cannabinoid profile and verifying absence of contaminants.

5. Documentation. Batch-specific COAs document the cannabinoid content and support buyer compliance review for the regulatory considerations specific to specialty cannabinoid analogs.

Manufacturing Applications

Specialty Multi-Cannabinoid Vape Products. EPN as a differentiation component in specialty vape cart products positioned around novel-cannabinoid content.

Premium Multi-Cannabinoid Blends. Used as a building block in premium multi-cannabinoid blends targeting connoisseur retail markets where novel-cannabinoid differentiation supports product positioning.

Specialty Tincture and Capsule Formulations. Used in branded specialty tinctures and capsules incorporating EPN.

Branded Specialty Products for Permissive Retail Markets. Used in private-label and branded specialty products distributed in retail markets with established compliance review protocols for specialty cannabinoid analogs.

Research and Development Applications. Used by formulators evaluating specialty cannabinoid analog behavior in finished product applications.

Quality Standards and Third-Party Lab Testing

EPN (Euphorinol) is sourced from suppliers operating cGMP-compliant production facilities equipped for specialty cannabinoid synthesis, with finished material independently tested through ISO 17025-accredited third-party laboratories. Every batch ships with a Certificate of Analysis documenting the cannabinoid profile and verifying absence of pesticides, heavy metals, residual solvents, and synthesis residuals. Comprehensive COA documentation supports buyer compliance review for the specific regulatory considerations applicable to specialty cannabinoid analogs.

Compliance and Regulatory Considerations

EPN (Euphorinol) is produced from USA-grown hemp source material meeting the 2018 Farm Bill cultivation definition. However, as a specialty cannabinoid analog, EPN occupies a complex regulatory position — the DEA has issued guidance suggesting specialty cannabinoid analogs may be controlled substances under the Federal Analog Act, depending on structural similarity to scheduled cannabinoids. Several states have enacted specific restrictions on synthetic and specialty cannabinoid analogs that may apply to EPN. Buyers are responsible for thoroughly verifying EPN regulatory status in target distribution markets and consulting with legal counsel before purchasing or distributing finished products. Sales of this product are restricted to buyers with verified compliance review protocols. We evaluate shipments to potentially restricted states on a case-by-case basis at order processing.

Storage and Handling

Store EPN (Euphorinol) in a cool, dry environment between 15–25°C (59–77°F), protected from direct light and air. Specialty cannabinoid analogs may be more sensitive to thermal and oxidative degradation than standard cannabinoids — sealed original packaging and refrigeration extend shelf life. Avoid prolonged exposure to temperatures above 30°C (86°F).

Bulk and Wholesale Volume Tiers

EPN (Euphorinol) is available in 100g, 250g, 500g, 1kg, 5kg, 10kg, 25kg, 50kg, and 100kg+ configurations with tiered pricing. Pricing reflects the specialty synthesis processing and compliance documentation requirements for specialty cannabinoid analogs.

Wholesale Buyers and Procurement Profiles

EPN (Euphorinol) is sourced by specialty manufacturers building branded multi-cannabinoid product lines around novel-cannabinoid content, by formulators developing premium specialty SKUs incorporating differentiated cannabinoid analogs, by private label operations supplying specialty cannabinoid products to permissive retail markets with established compliance review protocols, and by R&D operations evaluating specialty cannabinoid analog behavior. Sales are restricted to buyers with verified compliance review capabilities given the regulatory complexity of specialty cannabinoid analogs.

Submit an order request through the contact form on this page or call (303) 339-0343 for current pricing, COA documentation, and available volume.